Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burnier

Showing results (41-50 of 284) with videos related to

Pageof 29
Sort By:
BMJ (Clinical Research Ed.)|December 1, 2001
Antihypertensive treatment and compliance. Study was too short and lacked active interventionM Burnier, H R Brunner
Expert Opinion on Investigational Drugs|May 1, 1997
Angiotensin II receptor antagonists - antihypertensive agentsM Burnier, H R Brunner
Revue Medicale Suisse|April 6, 2011
[What is the best partner for nephrology?]M Burnier, P Y Martin
Therapie|October 17, 1998
[Angiotensin II AT1 receptor antagonists: clinical development and future perspectives]M Burnier, H R Brunner
Advances in Experimental Medicine and Biology|January 1, 1987
Pathogenesis of acute renal failureM Burnier, R W Schrier
Praxis|July 30, 1997
[Renal manifestations of viral diseases]A Péchère-Bertschi, M Burnier
European Journal of Clinical Pharmacology|October 17, 1998
On-line home monitoring of drug compliance: is it feasible?M P Schneider, M Burnier
Revue Medicale Suisse|April 18, 2007
[Controlled randomized studies do not always confirm the results suggested by observational studies]P Y Martin, M Burnier
Revue Medicale Suisse|April 2, 2013
[Nephrology between economy and ecology]M Burnier, P-Y Martin
Experimental Nephrology|January 1, 1996
Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjectsM Burnier, H R Brunner
Pageof 29

Showing results (41-50 of 284) with videos related to

Sort By:
Pageof 29
BMJ (Clinical Research Ed.)|December 1, 2001
Antihypertensive treatment and compliance. Study was too short and lacked active interventionM Burnier, H R Brunner
Expert Opinion on Investigational Drugs|May 1, 1997
Angiotensin II receptor antagonists - antihypertensive agentsM Burnier, H R Brunner
Revue Medicale Suisse|April 6, 2011
[What is the best partner for nephrology?]M Burnier, P Y Martin
Therapie|October 17, 1998
[Angiotensin II AT1 receptor antagonists: clinical development and future perspectives]M Burnier, H R Brunner
Advances in Experimental Medicine and Biology|January 1, 1987
Pathogenesis of acute renal failureM Burnier, R W Schrier
Praxis|July 30, 1997
[Renal manifestations of viral diseases]A Péchère-Bertschi, M Burnier
European Journal of Clinical Pharmacology|October 17, 1998
On-line home monitoring of drug compliance: is it feasible?M P Schneider, M Burnier
Revue Medicale Suisse|April 18, 2007
[Controlled randomized studies do not always confirm the results suggested by observational studies]P Y Martin, M Burnier
Revue Medicale Suisse|April 2, 2013
[Nephrology between economy and ecology]M Burnier, P-Y Martin
Experimental Nephrology|January 1, 1996
Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjectsM Burnier, H R Brunner
Pageof 29